Tripelennamine citrate

This classification denotes a histamine-1 receptor antagonist with the molecular formula C16H21N3.C6H8O7, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 30OC46A3J9, chemically known as 1,2-ethanediamine, n,n-dimethyl-n-(phenylmethyl)-n-2-pyridinyl-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1) but more generally known as tripelennamine citrate, which bears US NIH Compound Identifier 197066. European Medicines Agency schedules Tripelennamine citrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04980MIG. Most nations, for tariff and trade purposes, schedule tripelennamine citrate under HS 29333999 and SITC 51574. As of Q4 2014, TRIPELENNAMINE CITRATE remains US FDA's Preferred Term for this commodity. Tripelennamine citrate bears US NLM identifiers UMLS ID C0242524 and NCI Concept Code C66641. SMILES: CN(C)CCN(CC1CCCCC1)C2CCCCN2.C(C(=O)O)C(CC(=O)O)(C(=O)O)O.